Exclusive
If Canada Is Not Safe From Trump, Who Is? If Canada Is Not Safe From Trump, Who Is? The Price of Prabowo’s Centralization The Price of Prabowo’s Centralization Taiwan’s energy vulnerability makes the case for a nuclear rethink Taiwan’s energy vulnerability makes the case for a nuclear rethink
Current Affairs

SoftBank-backed surgical robotics firm eyes Hong Kong listing to power mainland China push

SoftBank-backed surgical robotics company Noah Medical has begun preparations for a Hong Kong initial public offering, joining a wave of cutting-edge technology firms tapping the…

By Samantha Johnson / August 28, 2026
SoftBank-backed surgical robotics company Noah Medical has begun preparations for a Hong Kong initial public offering, joining a wave of cutting-edge technology firms tapping the city’s international fundraising pool.

The US-headquartered company aimed to raise more than US$100 million and planned to file its listing application as early as next year, according to founder Zhang Jian.

“We want to expand our business in [mainland] China, and Hong Kong – as an international financial centre with a globally recognised stock exchange – is the natural choice for our listing,” Zhang said in an interview on the sidelines of MedTech World Asia in Hong Kong on Thursday.

The company plans to expand sales of its surgical robots in top-tier and emerging mainland cities, such as Hangzhou, capital of China’s eastern Zhejiang province.

Sir Run Run Shaw Hospital is a target customer, following regulatory approval from China’s drug regulator in November last year.

In Hong Kong, Prince of Wales Hospital had purchased Noah Medical’s equipment, Zhang said.

Currently, 90 per cent of the company’s revenue is generated in the United States, where surgical robots have treated about 15,000 patients.

Don't Miss: